MAX-40279 是FLT3激酶和FGFR激酶的双重有效抑制剂。MAX-40279 具有研究急性髓性白血病 (AML) 的潜力 (信息提取自专利 WO2021180032A1)。

MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032) [1].

2070931-57-4

C22H23FN6OS

438.52

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years